T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$3.3B |
| 2 |
Eli Lilly
LLY
|
+$2.75B |
| 3 |
AstraZeneca
AZN
|
+$1.98B |
| 4 |
Coupang
CPNG
|
+$1.54B |
| 5 |
Fortinet
FTNT
|
+$1.48B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$2.34B |
| 2 |
Morgan Stanley
MS
|
+$2.26B |
| 3 |
Airbnb
ABNB
|
+$2.04B |
| 4 |
Qualcomm
QCOM
|
+$1.95B |
| 5 |
NVIDIA
NVDA
|
+$1.81B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.35% |
| 2 | Healthcare | 16.19% |
| 3 | Consumer Discretionary | 15.55% |
| 4 | Financials | 12.84% |
| 5 | Communication Services | 12.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ILPT
2376
Industrial Logistics Properties Trust
ILPT
$611M
| $483K | ﹤0.01% |
20,874
-10
| -0% | -$224 |
|
2377
Empire State Realty Trust
ESRT
$836M
| $481K | ﹤0.01% |
43,185
-1,634
| -4% | -$17K |
|
2378
Vishay Precision Group
VPG
$908M
| $481K | ﹤0.01% |
15,612
+85
| +0.5% | +$2.83K |
|
2379
Progress Software
PRGS
$1.83B
| $480K | ﹤0.01% |
10,890
+1,640
| +18% | +$71.8K |
|
2380
Enova International
ENVA
$6.52B
| $478K | ﹤0.01% |
+13,486
| New | +$404K |
|
|
ESPR
2381
DELISTED
Esperion Therapeutics
ESPR
| $478K | ﹤0.01% |
17,042
+6,976
| +69% | +$206K |
|
2382
Conduent
CNDT
$252M
| $475K | ﹤0.01% |
71,301
+20,471
| +40% | +$117K |
|
2383
Fulgent Genetics
FLGT
$513M
| $475K | ﹤0.01% |
+4,914
| New | +$507K |
|
2384
Par Pacific Holdings
PARR
$4.12B
| $473K | ﹤0.01% |
33,522
+41
| +0.1% | +$637 |
|
2385
Canterbury Park Holding Corp
CPHC
$81.4M
| $471K | ﹤0.01% |
34,447
| – | – |
|
2386
Acushnet Holdings
GOLF
$5.25B
| $471K | ﹤0.01% |
11,388
+5,106
| +81% | +$217K |
|
|
GTY
2387
Getty Realty Corp
GTY
$2.05B
| $471K | ﹤0.01% |
16,623
+30
| +0.2% | +$839 |
|
|
LAND
2388
Gladstone Land Corp
LAND
$358M
| $470K | ﹤0.01% |
25,701
+135
| +0.5% | +$2.34K |
|
|
TRST
2389
Trustco Bank Corp NY
TRST
$971M
| $470K | ﹤0.01% |
12,767
+3,311
| +35% | +$117K |
|
2390
Energy Recovery
ERII
$399M
| $469K | ﹤0.01% |
25,572
-19,925
| -44% | -$319K |
|
|
CNSL
2391
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $469K | ﹤0.01% |
65,144
+5,532
| +9% | +$32.9K |
|
|
BCLI
2392
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
| $468K | ﹤0.01% |
8,144
+6,690
| +460% | +$505K |
|
|
DHIL
2393
DELISTED
Diamond Hill
DHIL
| $468K | ﹤0.01% |
3,003
+1,498
| +100% | +$231K |
|
|
DX
2394
Dynex Capital
DX
$3.23B
| $468K | ﹤0.01% |
24,721
+133
| +0.5% | +$2.45K |
|
|
GES
2395
DELISTED
Guess Inc
GES
| $467K | ﹤0.01% |
19,883
-7,119
| -26% | -$175K |
|
2396
Columbus McKinnon
CMCO
$550M
| $463K | ﹤0.01% |
8,768
-20
| -0.2% | -$954 |
|
|
USAK
2397
DELISTED
USA Truck Inc
USAK
| $462K | ﹤0.01% |
+24,200
| New | +$321K |
|
2398
Occidental Petroleum Corp Warrants
OXY.WS
$33.7B
| $461K | ﹤0.01% |
38,727
-662,793
| -94% | -$7.48M |
|
2399
AMERISAFE
AMSF
$504M
| $460K | ﹤0.01% |
7,181
-499
| -6% | -$30K |
|
2400
Cadiz
CDZI
$295M
| $460K | ﹤0.01% |
47,970
+7,262
| +18% | +$78K |
|
Similar funds
T. Rowe Price Associates's Q1 2021 Portfolio in Review
As of Q1 2021, T. Rowe Price Associates held 2,908 positions worth $999B, up 2.5% from $974B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
T. Rowe Price Associates's Q1 2021 filing shows 248 new, 1,171 increased, 1,334 reduced and 66 closed positions. Its largest new stake was Coupang: 33,380,859 shares worth $1.63B. The largest sale was NXP Semiconductors, an estimated $2.34B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2021 buy was Coupang: 33,380,859 shares worth $1.63B.
- T. Rowe Price Associates added most to Zoom in Q1 2021, an estimated $3.3B increase.
- T. Rowe Price Associates's biggest Q1 2021 reduction was NXP Semiconductors, cutting an estimated $2.34B.
- T. Rowe Price Associates fully exited CONCHO RESOURCES INC. in Q1 2021, selling an estimated $205M.
- T. Rowe Price Associates's ten largest holdings make up 24% of its $999B portfolio in Q1 2021.
- T. Rowe Price Associates opened 248 new positions and closed 66 in Q1 2021.
- T. Rowe Price Associates's portfolio value rose 2.5% quarter-over-quarter to $999B.
Based on T. Rowe Price Associates's 13F filing for Q1 2021, filed 17 May 2021.